EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 2

Melatonin

Also called: N-acetyl-5-methoxytryptamine

A hormone the brain produces in response to darkness that helps time circadian rhythms and sleep. Supplements can be made from animals or microorganisms but are most often made synthetically.

Category
Other
Forms
Synthetic melatonin (most products); tablets, capsules, liquids and gummies
Strongest evidence
A Strong
Reviewed
2026-10-28

Class 1 Well studied in people. A 2015 Cochrane review included 12 RCTs (774 patients) of melatonin given before surgery for anxiety before or after surgery: 8 compared melatonin with placebo and 4 with placebo and midazolam. [2]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

6 topics studied1 body area · strongest grade A

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Melatonin does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Melatonin, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Anxiety before surgery in adultsAA 2015 review of 12 studies (774 people) found strong evidence that melatonin beats placebo for anxiety before surgery; results for anxiety after surgery were mixed. [1]
Delayed sleep-wake phase disorderBA 2018 4-week RCT (307 people) found sleep onset about 34 minutes earlier with timed melatonin plus a set bedtime; AASM's 2015 recommendation was weak. [1]
Jet lagBReviews from 2010 and 2014 found melatonin may beat placebo for jet lag symptoms (4 studies, 142 travelers eastward; 2 studies, 90 travelers westward). [1]
Sleep problems in childrenBA 2019 review of 18 mostly small, 1-13 week studies (1,021 children) found faster sleep onset and longer sleep than placebo; effects on behavior were unclear and long-term effects unknown. [1]
Chronic insomnia in adultsCAASM (2017) and ACP (2016) guidelines found not enough strong evidence on effectiveness or safety to recommend melatonin for chronic insomnia. [1]
Sleep in shift workersCTwo 2014 reviews (263 and 300 participants) found studies generally small or inconclusive; daytime sleep was about 24 minutes longer, with low-quality evidence. [1]

Main constituents: Melatonin [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • In the 2018 trial in delayed sleep-wake phase disorder, melatonin was taken 1 hour before the desired bedtime, combined with going to bed at a set time, for 4 weeks. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E: unlikely cause of clinically apparent liver injury.

    Details and sources
  • Pregnancy and breastfeeding
    Research on the safety of melatonin in pregnancy and breastfeeding is lacking.

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    5 listed

    Nifedipine; CYP1A2 substrates (e.g. fluvoxamine); Anticoagulants and blood thinners; Blood thinners; epilepsy …

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    3 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada NNHPD monograph "Melatonin - Oral" (Canada; no revision date shown, accessed 2026-10-29), adults: 0.1–10 mg per day for the listed …

    Details and sources
  • Short-term use appears safe for most people, but information on long-term safety is lacking. Reported mild side effects in adults include headache, dizziness, nausea and sleepiness. [1]
  • Pregnancy and breastfeeding: research on safety is lacking. [1]
  • Older people: melatonin may stay active longer and cause daytime drowsiness; 2015 AASM guidelines recommend against melatonin use by people with dementia. [1]
  • Children: reports to US poison control centers about melatonin in people 19 and younger rose from 8,337 in 2012 to 52,563 in 2021; CDC estimated 11,000 emergency visits for unsupervised ingestion by children 5 and younger in 2019-2022. [1]
  • Because melatonin is a hormone, supplements could possibly affect hormonal development in children, including puberty, menstrual cycles and prolactin, but this is not known for sure. [1]
  • There may be a risk of allergic reactions. [1]
Interactions

Interactions

Melatonin
From the table below 2 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Melatonin
WithWhat happens
Blood thinners (anticoagulants)People taking blood thinner medications need to be under medical supervision when taking melatonin. [1]
Epilepsy and its medicinesPeople with epilepsy need to be under medical supervision when taking melatonin. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • A 2017 study of 31 melatonin supplements found that for most, the melatonin content did not match the label, and 26 percent contained serotonin. [1]
  • A 2023 study found 22 of 25 US melatonin gummy products inaccurately labeled: one had no detectable melatonin; the rest contained 74 to 347 percent of the labeled amount. [1]
Regulation

Regulatory status

  • US: considered a dietary supplement. In several other countries melatonin is available only with a prescription and is considered a drug. [1]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Melatonin (N-acetyl-5-methoxytryptamine) Indolamine hormone secreted by the pineal gland [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 3 entries naming melatonin (earliest NDI 243 submitted 2003-07-18; most recent NDI 756 submitted 2012-04-11); each names melatonin in a combination or with an adjuvant. A further entry (NDI 171, 2002-07-26) names N-acetylserotonin ("Normelatonin"), a different compound. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P6]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC carcinogenicity evaluation of melatonin was found (IARC Monographs list of classifications checked 2026-10-29). [P7]
  • No NTP technical report on melatonin was found (NTP technical reports list checked 2026-10-29). [P8]

Liver (NIH LiverTox)

  • LiverTox likelihood score E: unlikely cause of clinically apparent liver injury. Melatonin has not been implicated in causing serum enzyme elevations or clinically apparent liver injury (chapter last updated January 10, 2020). [P3]

Interactions with medicines

  • Nifedipine: Concomitant administration of melatonin and nifedipine has resulted in elevations in blood pressure and heart rate. [P1]
  • CYP1A2 substrates (e.g. fluvoxamine): Melatonin inhibits CYP1A2 and may increase the bioavailability of substrate drugs. [P1]
  • Anticoagulants and blood thinners: Oral melatonin is associated with lower plasma factor VIII and fibrinogen, which may increase the risk of adverse effects when used with anticoagulant medications. [P1]
  • Blood thinners; epilepsy: People taking blood thinner medications and people with epilepsy need to be under medical supervision when taking melatonin. [P2]
  • Medications for seizures, blood pressure or immune suppression: The Canadian monograph requires labels to advise consulting a health care practitioner before use if taking these medications. [P4]

Alcohol

  • The Canadian monograph label statement: "Avoid taking with alcohol or products that cause drowsiness." [P4]

Interactions with other herbs and supplements

  • Rhubarb: A study using human primary hepatocytes showed that concomitant use can cause metabolic disorder of melatonin (laboratory study). [P1]

Adulteration and substitution

  • A 2017 study of 31 melatonin supplements found that for most, the melatonin content did not match the label, and 26 percent contained serotonin. [P2]
  • A 2023 study found 22 of 25 US melatonin gummy products inaccurately labeled: one had no detectable melatonin; the rest contained 74 to 347 percent of the labeled amount. [P2]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination of each component that is a dietary ingredient, before use — Required by 21 CFR 111.75(a)(1)(i); a manufacturer may petition for an exemption from this testing under 111.75(a)(1)(ii). [P9]
  • Melatonin content assay against the label claim — Studies of US products found most melatonin supplements (2017) and 22 of 25 gummies (2023) did not match their labeled amount. [P2]
  • Serotonin screen — 26 percent of 31 melatonin supplements tested in a 2017 study contained serotonin. [P2]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • Systematic review of 22 human studies: bioavailability of oral melatonin ranged from 9% to 33% (approximately 15%); Tmax was approximately 50 minutes after oral immediate-release formulations; elimination half-life was 45 minutes. [P5]
  • Pharmacokinetics were affected by age, caffeine, smoking, oral contraceptives, feeding status and fluvoxamine. [P5]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada NNHPD monograph "Melatonin - Oral" (Canada; no revision date shown, accessed 2026-10-29), adults: 0.1–10 mg per day for the listed sleep uses and 0.5–10 mg per day for jet lag, taken once a day at or before bedtime; label advice to consult a practitioner for use beyond 4 weeks for some uses. [P4]

Pregnancy and breastfeeding

  • Research on the safety of melatonin in pregnancy and breastfeeding is lacking. [P2]
  • The Canadian monograph requires the label statement: "Do not use this product if you are pregnant or breastfeeding." [P4]

Sources for this profile

  1. Memorial Sloan Kettering Cancer Center. About Herbs: Melatonin (last updated July 30, 2026), 2026-07-30. mskcc.org
  2. NCCIH. Melatonin: What You Need To Know (Last Updated: May 2024), 2024-05. nccih.nih.gov
  3. NIH LiverTox (NIDDK). Melatonin (Last Update: January 10, 2020), 2020-01-10. ncbi.nlm.nih.gov
  4. Health Canada, Natural and Non-prescription Health Products Directorate. Monograph: Melatonin - Oral (no revision date shown on the page; accessed October 29, 2026), 2026-10-29. webprod.hc-sc.gc.ca
  5. Harpsøe NG, et al. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol 2015;71(8):901-9 (PMID 26008214), 2015-08. pubmed.ncbi.nlm.nih.gov
  6. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  7. IARC Monographs. List of Classifications (accessed October 29, 2026), 2026-10-29. monographs.iarc.who.int
  8. National Toxicology Program. Technical Reports (TR) list (accessed October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
  9. eCFR. 21 CFR 111.75 (title 21 displayed up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. NCCIH. Melatonin: What You Need To Know (Last Updated: May 2024), 2024-05. nccih.nih.gov
  2. Hansen MV, et al. Melatonin for pre- and postoperative anxiety in adults. Cochrane Database Syst Rev 2015;(4):CD009861 (PMID 25856551), 2015-04-09. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.